Physician profile
Robert G Lewcun
NPI 1467490516
$983.54
in general payments reported to CMS, 2019-2025
23 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $131 · 2021: $111 · 2022: $101 · 2023: $148 · 2024: $178 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $211.42 | 2021-2025 | |
| Pfizer INC. | $127.86 | 2019-2025 | |
| Glaxosmithkline, LLC. | $76.06 | 2020-2025 | Arexvy, Shingrix |
| Sanofi Pasteur INC. | $56.51 | 2020-2023 | |
| Abbott Laboratories | $54.77 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Allergan, INC. | $50.60 | 2020 | |
| Seqirus USA INC | $50.17 | 2021-2025 | Fluad, Flucelvax |
| Astrazeneca Pharmaceuticals LP | $44.80 | 2020-2024 | Breztri |
| Genentech USA, INC. | $32.56 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $30.83 | 2025 | |
| Philips North America LLC | $29.90 | 2019-2020 | |
| Novo Nordisk INC | $24.77 | 2025 | |
| Lilly USA, LLC | $21.17 | 2024 | Mounjaro |
| Metuchen Pharmaceuticals | $20.44 | 2019 | |
| Inspire Medical Systems, INC. | $19.72 | 2025 | Inspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $19.59 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $19.01 | 2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Novartis Pharmaceuticals Corporation | $18.18 | 2022 | |
| Hologic Sales and Service, LLC | $17.43 | 2024 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.63 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.61 | 2020 | |
| Mylan Specialty L.P. | $13.78 | 2019 | |
| Amarin Pharma, INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lewcun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.